Answers are grounded in this paper and cite their sources.
As a common disease of the digestive system, gallstones have an increasing incidence globally. Cholesterol gallstones account for 75% of all gallstones in westernized people. In recent years, the role of metabolic factors in the pathogenesis of gallstones has garnered significant attention. The association between abnormal pancreatic islet function and hyperinsulinaemia, as the core link of metabolic disorders, and gallstones has been confirmed by numerous clinical studies. This narrative review describes the aetiology and pathological features of hyperinsulinaemia, focusing on the molecular mechanisms by which hyperinsulinaemia promotes gallstone formation via pathways including cholesterol synthesis, secretion, absorption, and gallbladder contraction dysfunction. Although studies have shown a high correlation between hyperinsulinaemia and gallstones, the paradox of rapid weight loss and the risk associated with enteropancreatic drugs suggest that the onset of gallstones is a multifactorial process and cannot be explained solely by hyperinsulinaemia. The hypotheses of insulin regulating gallbladder epithelial mucin and upregulating NPC1L1 to promote cholesterol absorption still lack direct human experimental evidence. hyperinsulinaemia This review focuses on the pathways underlying hyperinsulinaemia-mediated cholesterol gallstone disease and lays a foundation for subsequent mechanistic investigations.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: